e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Biomarkers and assessment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Systemic inflammation in exacerbated patients with chronic obstructive pulmonary disease (COPD): the role of alterations in leptin/ghrelin ratio and/or leptin/adiponectin ratio
G. Krommidas, G. Papatheodorou, D. Markoulaki, N. Koulouris, N. Chatzianastasiou, C. Roussos, S. Loukides (Athens, Greece)
Source:
Annual Congress 2007 - Biomarkers and assessment of COPD
Session:
Biomarkers and assessment of COPD
Session type:
Oral Presentation
Number:
417
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Krommidas, G. Papatheodorou, D. Markoulaki, N. Koulouris, N. Chatzianastasiou, C. Roussos, S. Loukides (Athens, Greece). Systemic inflammation in exacerbated patients with chronic obstructive pulmonary disease (COPD): the role of alterations in leptin/ghrelin ratio and/or leptin/adiponectin ratio. Eur Respir J 2007; 30: Suppl. 51, 417
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
The role of CD4/CD8 ratio in development of chronic obstructive pulmonary disease (COPD) among smokers
Source: Eur Respir J 2002; 20: Suppl. 38, 94s
Year: 2002
Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 363s
Year: 2007
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept